Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jiajia Wu, Jianxiao Shen, Wanpeng Wang, Na Jiang, Haijiao Jin, Xiajing Che, Zhaohui Ni, Yan Fang & Shan Mou. (2022) A novel contrast-induced acute kidney injury mouse model based on low-osmolar contrast medium. Renal Failure 44:1, pages 1346-1356.
Read now
Read now
Articles from other publishers (3)
Marcello RubinoJoshua G. Travers, Alaina L. HeadrickBlake T. Enyart, Madeleine E. Lemieux, Maria A. CavasinJessica A. SchwisowElizabeth J. HardyKeenan J. KaltenbacherMarina B. FelisbinoEric Jonas, Amrut V. Ambardekar, Michael R. Bristow, Keith A. Koch & Timothy A. McKinsey. (2023) Inhibition of Eicosanoid Degradation Mitigates Fibrosis of the Heart. Circulation Research 132:1, pages 10-29.
Crossref
Crossref
Aikaterini Kourpa, Debora Kaiser-Graf, Anje Sporbert, Aurélie Philippe, Rusan Catar, Michael Rothe, Eva Mangelsen, Angela Schulz, Juliane Bolbrinker, Reinhold Kreutz & Daniela Panáková. (2022) 15-keto-Prostaglandin E2 exhibits bioactive role by modulating glomerular cytoarchitecture through EP2/EP4 receptors. Life Sciences 310, pages 121114.
Crossref
Crossref
Chen-Chen Sun, Zuo-qiong Zhou, Dong Yang, Zhang-lin Chen, Yun-yi Zhou, Wei Wen, Chen Feng, Lan Zheng, Xi-Yang Peng & Chang-Fa Tang. (2021) Recent advances in studies of 15-PGDH as a key enzyme for the degradation of prostaglandins. International Immunopharmacology 101, pages 108176.
Crossref
Crossref